EYEG insider trading

NasdaqGM

EYEGATE PHARMACEUTICALS INC: insider trade history from SEC Form 4 filings.

Total Form 4 trades
335
Last 90 days
0
Buys / sells
36% / 11%
Market cap
—

About EYEGATE PHARMACEUTICALS INC

The fund pursues its objective by investing, under normal circumstances, at least 80% of its net assets, including any borrowings for investment purposes, in investment grade fixed-income securities of corporate issuers. Corporate issuers may include corporate or other business entities in which a sovereign or governmental agency or entity may have, indirectly or directly, an interest, including a majority or greater ownership interest.

EYEG insider activity at a glance

FilingIQ tracks 335 insider transactions for EYEG in filings since Feb 23, 2015. The most recent transaction is dated Nov 2, 2021.

Across the full history, 122 open-market purchases and 37 open-market sales were filed under transaction codes P and S respectively. Compensatory share awards (code A) and option exercises (code M) are tracked separately and not counted here.

The average FilingIQ composite score on EYEG insider trades is 62.0/100, produced by FilingIQ's multi-factor Form 4 model. Model framework documented at methodology.

Latest EYEG Form 4 filings

Most recent disclosures. Sign up to filter by score, transaction code, or insider role.

Frequently asked

How many insider trades does FilingIQ track for EYEG?
FilingIQ tracks 335 Form 4 insider transactions for EYEG (EYEGATE PHARMACEUTICALS INC), covering filings from Feb 23, 2015 onwards. 0 of those are dated within the last 90 days.
Are EYEG insiders net buyers or net sellers?
Across the full Form 4 history for EYEG, 122 transactions (36%) were open-market purchases and 37 (11%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.
Where does EYEG insider data come from?
Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ normalises insider identity across reporting variations and scores discretionary open-market purchases and sales on its multi-factor composite model.

Methodology & sources

Every EYEG insider transaction shown on FilingIQ is parsed directly from a public SEC Form 4 XML filing. Insider identity is normalised across reporting variants (CIK changes, name spellings, related-party indirect holdings). The FilingIQ composite score is documented in full on the team page and algo disclosure. Not investment advice; see disclaimer.